CVI Holdings’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-128,241
Closed -$1.3M 424
2022
Q4
$1.3M Sell
128,241
-24,798
-16% -$247K 0.17% 169
2022
Q3
$1.5M Hold
153,039
0.12% 274
2022
Q2
$1.5M Hold
153,039
0.11% 298
2022
Q1
$1.5M Buy
153,039
+3,039
+2% +$29.6K 0.1% 325
2021
Q4
$1.46M Hold
150,000
0.1% 311
2021
Q3
$1.46M Hold
150,000
0.09% 314
2021
Q2
$1.46M Buy
+150,000
New +$1.46M 0.1% 283

Other funds holding COCH

CVI Holdings's COCH Position: Q1 2023 in Review

CVI Holdings sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 128,241 shares — an estimated $1.3M sold.

CVI Holdings first reported a position in COCH in Q2 2021 and held it in 7 quarters. The position peaked at $1.5M in Q3 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

  • CVI Holdings reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
  • CVI Holdings sold 128,241 Envoy Medical shares in Q1 2023, an estimated $1.3M.
  • CVI Holdings first reported a position in Envoy Medical in Q2 2021 and held it in 7 quarters.
  • CVI Holdings's Envoy Medical position peaked at $1.5M in Q3 2022.
  • 24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on CVI Holdings's 13F filing for Q1 2023, filed 16 May 2023.